On September 12, 2016, in a cafe in Nanshan, Shenzhen, three young people finalized a venture plan. After 11 days, they became a partner to set up a company, named a Maxi robot.
It has been in the past two months today. On the day of the double eleven, the Maxi robot released its first skeleton robot - Bear-H1 for hemiplegia. The mission of this robot is also very clear: help every person sitting on a wheelchair back walking.
Just a year ago, only three members of Meiji, that is, Chen Gong (CEO), Ye Jing (CTO) and Hu Feng (COO); the office area is only one of six plaids, located in Nanshan In an incubator in a software industry base.
He graduated from Shanghai Jiaotong University, and then went to Singapore National University to study his Ph.D., the topic of research is the interaction of RECRUAL Skeleton Robots and Flexo Drive. During the reading period, Chen Gong met the post-Japanese Ph.D. Ye Jing, Ye Jing graduated from the University of Japan, and the Digital Digo, the father of Japan's imitation robot, and the research direction has been related to the external bone robot.
Be
Dr. Chen Gong, Joint Founder and CEO of Machi Robot
Chen Gong recalls that before the establishment of step, the idea of entrepreneurship has been brewed and prepared for two years. After completing the doctoral thesis, the research and development of the foreign bone robot has been put into the foreign bone robot.
During this period, they have returned to China and finally examined a few cities, and finally chose to Shenzhen, one of the important causes is to look at the power chain supporting and manufacturing capacity of the Pearl River Delta.
After graduating from Dr., Chen Gong also found Hu Feng in the automation equipment and robotic industry, with rich operation and management experience, the idea of the three people's entrepreneurship, and then registered established the company. In April this year, Maxi Robot won the angel round financing of Lenovo Venture Group, and the company also entered the development of the fast track.
In the past, in just a year, stepped from a small team with only 3 people to nearly 30 people, and the office area moved to 1000 square meters from six people. After three generations of product prototypes, stepping The team eventually polls the mature-scale application robot BEAR-H1, and has successfully entered the hospital to achieve clinical testing.
The world's first flexible drive is only 1/3 of foreign product products.
Chen Gong said that the biggest feature of the Bear-H1 foreign bone robot is that the flexible drive is used as an output and is the world's first. At present, existing existing skeleton robots in the United States, Japan, is a rigid drive.
The advantage of the flexible drive is that in the scene of human-computer interaction, it does not require power and the torque sensor, which not only improves the stability and accuracy of force control, but also improves safety, and saves energy consumption. .
Be
At the press conference, the Maxi robot engineer showed the effect of the live-H1 walking and successfully demonstrated the entire walking process.
It is understood that Bear-h1 has 6 joints (bilateral hips, knee, ankle), and hip rotation assist joints, which can achieve natural gaits, suitable for patients with height of 150-190 cm, body weight less than 85kg. And its outer skeleton is adjustable, equipped with a gait monitoring assessment system, physiotherapist or family can monitor patient movement data by touching the screen real-time.
"This robot has installed a lot of sensors, which can detect the body's motion state in real time. The intent of the human body can be predicted through a specific AI algorithm, such as the speed of movement, start and stop, left leg or right leg, etc. Information will be collected and used to control the robot. "Chen Gong further introduced.
Highly selling prices have always made the most of the patients with other hemiplegia to expect the foreign bone machine.
It is understood that there are currently 20-10 million yuan of REWALK and Japan's Cyberdyne, with average price of 60-1 million yuan, and even have a similar product price up to 2.5 million yuan, and it is often only available. Way to use it for demand.
In contrast, the price advantage of Maiji has been obvious. According to Chen Gong, after the deposited outer skeleton robot product is invested in the market, the price will be half of the foreign products and even 1/3, which is functioning with these international brands.
The foreign bone robot market is expected to reach 100 billion, but it is a difficult bone.
According to the forecast of the third-party consulting institution, the annual composite growth rate of the Guangyi rehabilitation robot in the next five years is about 37%, of which the annual compound growth rate of the outer bone machine is 47%, which is much higher than the average increase in medical robots in other categories. Speed, the future market capacity can reach 100 billion levels.
China has a large number of China, which will undoubtedly become a large country of foreign bone products. Behind the market rapid development, there are two main reasons:
One is accompanied by my country's accelerating the aging society, the incidence of brain stroke is getting higher and higher. At present, the number of Chinese-striped patients in my country has exceeded 10 million, and it is still growing at a rate of 10% annually. In Europe, the United States, Japan's developed countries is more serious.
Second, the lack of medical resources, my country's professional stroke patients with severe resources are serious, according to the number of domestic strihy patients, about more than 400,000 rehabilitation physicians, however, professional practitioners are only about 20,000, and the gap is huge.
Be
Development plan for the future of Maxi robot
Although the foreground is considered, the outer skeleton robot is still a difficult bone. On the one hand, it is because the industry technology is high, the research and development cost is high, the product experience is not perfect; on the other hand, because of the particularity of the medical industry, the outer bone robot has not yet been included in our medical insurance system, and ordinary people are not affordable.
From the perspective of product commercialization, Israel's Rewalk, US EKSO has got the US FDA certification and entered the listing sales. Although there are also many listed companies and entrepreneurship companies involved in this area, there is no company has received CFDA certification so far, and has not truly product enters commercial. Technology area
Will AI and robots dig pit on the road of human future?
Entropy Technology gives robotic awareness and "hand-in coordination" capabilities
How to integrate Tuling robots, simply realize voice chat
Small fish accompanied by dozens of patented techniques at home
Xiaomi is planning a line SIMI football robot is expected to be one of the explosive toys in 2018.
Our other product:
